Menu

Compare stocks

Add stock  Remove all

Dates End of financial period

 #1#2#3#4#5#6#7#8
Remove  Pfizer IncJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24
Remove  Analog Devices IncAug 26May 26Jan 26Nov 25Aug 25May 25Feb 25Nov 24
Remove  T-Mobile US, Inc.Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24
Remove  Exelon CorpMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Remove  Howmet Aerospac...Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24

Profit ROIC / ROE/ROA / ROE / ROA

 #1#2#3#4
Pfizer Inc (ROE/ROA)36.4%40.7%42.5%42.1%
Analog Devices Inc (ROIC)8.9%7.5%6.3%5.6%
T-Mobile US, Inc. (ROE/ROA)60.2%60.8%61.3%61.8%
Exelon Corp (ROIC)5.7%5.7%5.8%5.7%
Howmet Aerospace Inc. (ROIC)22.7%23.1%21.2%20.1%

Growth Sales and OCF growth / Sales and net income growth

 #1#2#3#4
Pfizer Inc-5.1%-5.4%-4.4%17.7%
Analog Devices Inc31.6%29.1%26.5%19.0%
T-Mobile US, Inc.10.7%12.2%14.1%13.0%
Exelon Corp9.1%7.8%9.5%5.7%
Howmet Aerospace Inc.28.4%25.0%21.4%17.4%

Payout Shareholder distributions / net income

 #1#2#3#4#5
Pfizer Inc150%127%123%121%152%
Analog Devices Inc135%149%163%172%174%
T-Mobile US, Inc.141%142%128%127%120%
Exelon Corp58%60%58%60%59%
Howmet Aerospace Inc.61%57%57%55%50%